WO2008068656A2 - Dermatological compositions - Google Patents
Dermatological compositions Download PDFInfo
- Publication number
- WO2008068656A2 WO2008068656A2 PCT/IB2007/054552 IB2007054552W WO2008068656A2 WO 2008068656 A2 WO2008068656 A2 WO 2008068656A2 IB 2007054552 W IB2007054552 W IB 2007054552W WO 2008068656 A2 WO2008068656 A2 WO 2008068656A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- composition according
- weight
- yoghurt
- oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- This invention is related to the usage of yoghurt as a vehicle or an active ingredient in pharmaceutical, cosmetic, and cosmeceutical products due to its emollient, cicatrising and moisturizing effects.
- Yoghurt plays a big role on human's nutrition by its substantial amount of lactose, protein, fat, vitamin, calcium and phosphor. Also, it is known that many minerals, proteins, enzymes, fats and other beneficial bacteria's in Yoghurt have a big impact on skin. Yoghurt brightens and moisturizes the skin whereas it also has various ways to use it in cosmetics.
- the European Patent EP 0315541 discloses the use of yoghurt and kefir for cosmetic purposes.
- the cosmetic composition in powder form contains from 50 to 85% by weight of lyophilised yoghurt or kefir capable of being revivified, and at least one acidity acceptor for acid.
- the Italian Patent IT 1265930 discloses a cosmetic composition
- a cosmetic composition comprising yoghurt proteins and birch extract in appropriate quantities having a nutrient, elasticising and sebo-balancing effect on the scalp and a restructuring effect on hair.
- the yoghurt proteins and the birch extract are contained in the composition in a ratio of approximately 1 :3.
- Patent WO 2005087190 discloses a cosmetic composition that can provide skin moisturizing and softening effects improved by further containing vegetable and fruits extracts or milk, vitamins or yoghurt powder. In addition, it may contain xanthan gum and mannan to give the appearance and texture of curd yoghurt.
- yoghurt is used as a vehicle or an active substance due to emollient effect of its components such as lactic acid, essential oil acids, enzymes, proteins, fats, vitamins, and minerals. Lactic acid is also used as a moisturizer on dry skin. Furthermore, the compositions contain together with yoghurt also olive oil and almond oil that support skin barrier properties via supplying essential oil acids and squalen to the skin, and also dexpanthenol that has cicatrising effect.
- the aim of this invention is the use of yoghurt in the compositions of the medical dermatological, cosmetic, cosmeceutical creams, lotions and ointments to benefit from its emollient, cicatrising and moisturizing effect.
- compositions regarding cosmetic, cosmeceutical and pharmaceutical use of yoghurt are formed benefiting from its emollient effect due to its components such as lactic acid, essential oil acids, enzymes, proteins, fats, vitamins, and minerals.
- yoghurt is used in the compositions as a moisturizer due to the moisturizing effect of its component lactic acid on dry skin.
- Yoghurt is used as a vehicle or an active substance at a concentration of 1 to 99 % in the compositions in the form of cream, ointment, lotion, emulsion, foam, solution, emulsiogel, gel or aerosol foam.
- compositions contain together with yoghurt also olive oil and almond oil that support skin barrier properties via supplying essential oil acids and squalen to the skin, and also dexpanthenol that has cicatrising effect.
- compositions 1 to 50 % olive oil, 1 to 50 % almond oil and 0.01 to 10 % dexpanthenol are used.
- yoghurt in the compositions, yoghurt can be used as in its natural form or used after drying processes like spraying, lyophilizing.
- Yoghurt having cicatrising property, is used in the medical dermatological, cosmetic and cosmeceutical skin products for the treatment of wounds, burns, eczema, psoriasis, dermatitis due to its nutritive effect.
- Yoghurt is used for regulating skin flora, removing dryness and nutritive and supporting skin barrier properties via in a vehicle or alone.
- the various compositions comprising yoghurt, almond oil, olive oil and dexpanthenol are obtained. These compositions comprise:
- the oil which is selected from vegetable, organic or inorganic oils other than the olive oil and almond oil; -organic emulgators which comprise lecithin, tween 80, tweens, spans, sorbitan esters and analogouses or inorganic emulgators which comprise sodium laurilsulfate and analogouses;
- -vehicle products such as cetostearyl alcohol, glycerine monostearate, polyoxyl-
- BHT citric acid
- ascorbic acid hyaluronic acid vitamin E
- EDTA ethylenediaminetetraacetic acid
- -preservatives which comprise benzoic acid, sorbic acid, arlagard, benzyl alcohol and their analogouses.
- Yoghurt is added to the mixture while forming the emulsion at a high temperature or added after cooling the emulsion to the room temperature.
- Cream :
- Aqueous phase and oil phase are separately heated to 70 0 C and then emulsified.
- Yoghurt is added after cooling the emulsion to the room temperature and the obtained product is homogenized.
- Polioksil 40 Stearate i g
- Aqueous phase and oil phase are separately heated to 70 0 C and then mixed under homogenisation. The mixture is filled into the aerosol container.
- Yoghurt, water and arlagard are mixed and heated to 70 0 C.
- Other ingredients except bufexamac are added to the mixture and homogenized. After cooling the gel to the room temperature bufexamac is added and homogenized.
- Analgesics, antihelmintics, antiallergics, antibiotics, antiseptics, antimicotics, external antiparasites, antiphlogistics, corticosteroids, sulfamides, cicatrising ingredients and active ingredients used for the treatment of burn may also added to the above mentioned compositions. These ingredients may be added to the mixture while forming the product or added to the finished product at room temperature and homogenized.
- the examples to the said compositions are given below:
- Urea is used in a concentration of 5 to 40 % in the above composition. Further, oil-in-water (O/W) emulsions and water-in-oil (W/O) emulsions also can be used.
- O/W oil-in-water
- W/O water-in-oil
- corticosteroids selected from high potency or medium potency corticosteroid group (group I, group II, group III) can be used in various concentrations instead of hydrocortisone acetate, a low potency corticosteroid (group IV). Corticosteroids are used in a concentration of 0.001 to 2.5 % due to their activity.
- anticeptics or/and some active ingredients with cicatrising effect can be used in various concentrations instead of using silver sulfadiazine.
- hydrocortisonacetate cortisone
- clindamycin antibiotic
- compositions which are the subject matter of the invention are applied topically to the skin.
- compositions comprising yoghurt, olive oil, almond oil and dexpanthenol can be formulated.
- yoghurt can be used as natural or used after drying processes like spraying, lyophilizing.
Abstract
In this present invention yoghurt is used as a vehicle product or an active substance due to emollient effect of its components such as lactic acid, essential oil acids, enzymes, proteins, fats, vitamins, and minerals. Lactic acid is also used as a moisturizer on dry skin. Furthermore, the compositions contain together with yoghurt also olive oil and almond oil that support skin barrier properties via supplying essential oil acids and squalen to the skin, and also dexpanthenol that has cicatrising effect.
Description
DESCRIPTION
DERMATOLOGICAL COMPOSITIONS
Technical Field:
This invention is related to the usage of yoghurt as a vehicle or an active ingredient in pharmaceutical, cosmetic, and cosmeceutical products due to its emollient, cicatrising and moisturizing effects.
Background of Invention:
It is known that yoghurt plays a big role on human's nutrition by its substantial amount of lactose, protein, fat, vitamin, calcium and phosphor. Also, it is known that many minerals, proteins, enzymes, fats and other beneficial bacteria's in Yoghurt have a big impact on skin. Yoghurt brightens and moisturizes the skin whereas it also has various ways to use it in cosmetics.
The European Patent EP 0315541 discloses the use of yoghurt and kefir for cosmetic purposes. The cosmetic composition in powder form contains from 50 to 85% by weight of lyophilised yoghurt or kefir capable of being revivified, and at least one acidity acceptor for acid.
The Italian Patent IT 1265930 discloses a cosmetic composition comprising yoghurt proteins and birch extract in appropriate quantities having a nutrient, elasticising and sebo-balancing effect on the scalp and a restructuring effect on hair. Preferably the yoghurt proteins and the birch extract are contained in the composition in a ratio of approximately 1 :3.
The Patent WO 2005087190 discloses a cosmetic composition that can provide skin moisturizing and softening effects improved by further containing vegetable and fruits extracts or milk, vitamins or yoghurt powder. In addition, it may contain xanthan gum and mannan to give the appearance and texture of curd yoghurt.
In the composition which is the subject matter of the invention yoghurt is used as a vehicle or an active substance due to emollient effect of its components such as lactic acid, essential oil acids, enzymes, proteins, fats, vitamins, and minerals.
Lactic acid is also used as a moisturizer on dry skin. Furthermore, the compositions contain together with yoghurt also olive oil and almond oil that support skin barrier properties via supplying essential oil acids and squalen to the skin, and also dexpanthenol that has cicatrising effect.
Aim of Invention:
The aim of this invention is the use of yoghurt in the compositions of the medical dermatological, cosmetic, cosmeceutical creams, lotions and ointments to benefit from its emollient, cicatrising and moisturizing effect.
Description of Invention:
The subject matter of the invention, compositions regarding cosmetic, cosmeceutical and pharmaceutical use of yoghurt are formed benefiting from its emollient effect due to its components such as lactic acid, essential oil acids, enzymes, proteins, fats, vitamins, and minerals. Especially yoghurt is used in the compositions as a moisturizer due to the moisturizing effect of its component lactic acid on dry skin. Yoghurt is used as a vehicle or an active substance at a concentration of 1 to 99 % in the compositions in the form of cream, ointment, lotion, emulsion, foam, solution, emulsiogel, gel or aerosol foam.
Furthermore, the compositions contain together with yoghurt also olive oil and almond oil that support skin barrier properties via supplying essential oil acids and squalen to the skin, and also dexpanthenol that has cicatrising effect.
Within the scope of the compositions 1 to 50 % olive oil, 1 to 50 % almond oil and 0.01 to 10 % dexpanthenol are used.
In the compositions, yoghurt can be used as in its natural form or used after drying processes like spraying, lyophilizing.
Yoghurt, having cicatrising property, is used in the medical dermatological, cosmetic and cosmeceutical skin products for the treatment of wounds, burns, eczema, psoriasis, dermatitis due to its nutritive effect. Yoghurt is used for regulating skin flora, removing dryness and nutritive and supporting skin barrier properties via in a vehicle or alone.
The various compositions comprising yoghurt, almond oil, olive oil and dexpanthenol are obtained. These compositions comprise:
-the oil which is selected from vegetable, organic or inorganic oils other than the olive oil and almond oil; -organic emulgators which comprise lecithin, tween 80, tweens, spans, sorbitan esters and analogouses or inorganic emulgators which comprise sodium laurilsulfate and analogouses;
-vehicle products such as cetostearyl alcohol, glycerine monostearate, polyoxyl-
40-stearate, solid paraffin, cetil alcohol, tegesoft DO, fatty acid esters, vaseline and analogouses;
-antioxidants which comprise butylhydroxyanisol (BHA), butylhydroxytoluol
(BHT), citric acid, ascorbic acid, hyaluronic acid vitamin E; ethylenediaminetetraacetic acid (EDTA) and analogouses,
-preservatives which comprise benzoic acid, sorbic acid, arlagard, benzyl alcohol and their analogouses.
The examples to the compositions formed by above mentioned ingredients are given below:
Examples:
Lotion:
The ingredients of the composition in the form of lotion are given below.
Yoghurt (fresh or strained or dried) 2O g
Dexpanthenol 2 g
Olive oil 7 g
Hyaluronic acid 1.5 g
Vitamin E 0.1 g
Lecithin 1.5 g
Arlagard 0.3 g
Water 67.6 g
Yoghurt is added to the mixture while forming the emulsion at a high temperature or added after cooling the emulsion to the room temperature.
Cream:
The ingredients of the composition in the form of cream are given below.
Yoghurt 2Og
Dexpanthenol 2g
Olive oil 5g
Almond oil 5g
Cetostearyl alcohol 2g
Glicerin monostearate 2g
Tween 80 2g
BHA 0.1 g
Arlagard 0.3 g
Vitamin E 0.1 g
Water 61.5g
Aqueous phase and oil phase are separately heated to 70 0C and then emulsified. Yoghurt is added after cooling the emulsion to the room temperature and the obtained product is homogenized.
Foam:
The ingredients of the composition in the form of foam are given below.
Triamcinolone 0.5 g
Yoghurt 10g
Olive oil 2g
Almond oil 2g
Cetostearyl alcohol i g
Dexpanthenol i g
Tegosoft DO 2.5 g
Polioksil 40 Stearate i g
Arlagard 0.15g
Vitamin E 0.1 g
BHA 0.1 g
EDTA 0.1 g
Propellant 2.5 g
Water 77.05 g
Aqueous phase and oil phase are separately heated to 70 0C and then mixed under homogenisation. The mixture is filled into the aerosol container.
Gel:
The ingredients of the composition in the form of gel are given below.
Bufexamac 5 g Yoghurt 20 g
Sepigel 305 2 g
Olive oil 2 g
Almond oil 2 g
Arlagard 0.3 g Water 68.7 g
Yoghurt, water and arlagard are mixed and heated to 70 0C. Other ingredients except bufexamac are added to the mixture and homogenized. After cooling the gel to the room temperature bufexamac is added and homogenized.
Analgesics, antihelmintics, antiallergics, antibiotics, antiseptics, antimicotics, external antiparasites, antiphlogistics, corticosteroids, sulfamides, cicatrising ingredients and active ingredients used for the treatment of burn may also added to the above mentioned compositions. These ingredients may be added to the mixture while forming the product or added to the finished product at room temperature and homogenized. The examples to the said compositions are given below:
Example 1 :
Urea 5 g
Yoghurt 2O g
Dexpanthenol 2 g
Olive Oil 5 g
Almond Oil 5 g
Cetostearyl alcohol 2 g
Glicerin monostearate 2 g
Tween 80 2 g
BHA 0.1 g
Arlagard 0.3 g
Vitamin E 0.1 g
Water 56.5 g
Urea is used in a concentration of 5 to 40 % in the above composition. Further, oil-in-water (O/W) emulsions and water-in-oil (W/O) emulsions also can be used.
Example 2:
Hydrocortisone acetate 0.1 g
Yoghurt 2O g
Dexpanthenol 2 g
Olive Oil 5 g
Almond Oil 5 g
Cetostearyl alcohol 2 g
Glicerin monostearate 2 g
Tween 80 2 g
BHA 0.1 g
Arlagard 0.3 g
Vitamin E 0.1 g
Water 61.4 g
Further, in the composition mentioned above, other corticosteroids selected from high potency or medium potency corticosteroid group (group I, group II, group III) can be used in various concentrations instead of hydrocortisone acetate, a low potency corticosteroid (group IV). Corticosteroids are used in a concentration of 0.001 to 2.5 % due to their activity.
Example 3:
Silver sulfadiazine 2 g
Yoghurt 2O g
Dexpanthenol 2 g
Olive Oil 5 g
Almond Oil 5 g
Cetostearyl alcohol 2 g
Glicerin monostearate 2 g
Tween 80 2 g
BHA 0.1 g
Arlagard 0.3 g
Vitamin E 0.1 g
Water 59.5 g
Further, in the above composition of cream for the burn treatment, anticeptics or/and some active ingredients with cicatrising effect can be used in various concentrations instead of using silver sulfadiazine. For example, hydrocortisonacetate (cortisone) can be used in an amount of 0.5 to 2.5% by weight of the composition, or clindamycin (antibiotic) can be used in an amount of 1 to 2% by weight of the composition.
The compositions which are the subject matter of the invention are applied topically to the skin.
As mentioned above different compositions comprising yoghurt, olive oil, almond oil and dexpanthenol can be formulated. In the compositions, disclosed herein, yoghurt can be used as natural or used after drying processes like spraying, lyophilizing.
Claims
1. A composition that comprises the use of yoghurt as a vehicle or an active substance in dermatological, cosmetic, cosmeceutic and pharmaceutical skin products due to the moisturizing, softening and cicatrising effects, characterized in that, it comprises yoghurt, dexpanthenol, at least one oil, at least one emulgator, at least one vehicle product, at least one antioxidant, water and at least one preservative.
2. The composition according to claim 1 , where in;
yoghurt is about 1 to 99% by weight of the composition, - dexpanthenol is about 0,01% - 10% by weight of the composition, oil is about 1 to 50% by weight of the composition, emulgator is about 1 to 5% by weight of the composition,
- vehicle is about 1 to 5% by weight of the composition,
- antioxidant is about 0.1 to 5% by weight of the composition, - preservative is about 0.1 to 5% by weight of the composition,
- water is about 40 to 70% by weight of the composition.
3. The composition according to claim 1 and 2, wherein said oil is selected from the group consisting of olive oil, almond oil, vegetable oil, organic and inorganic oils.
4. The composition according to claim 1 and 2, wherein said emulgator is selected from the group consisting of lecithin, tween 80, tweens, spans, organic emulgators including sorbitan esters or inorganic emulgators including sodium laurilsulphate and its analogouses.
5. The composition according to claim 1 and 2, wherein said vehicle product is selected from the group consisting of cetostearyl alcohol, glyceryl monostearate, polyoxyl-40-stearate, solid paraffin, cetil alcohol, oil acid esters, tegesoft DO and vaseline.
6. The composition according to claim 1 and 2, wherein said antioxidant is selected from the group consisting of butylhydroxyanisol (BHA), butylhydroxytoluol (BHT), citric acid, ascorbic acid, vitamin E, ethylenediaminetetraacetic acid (EDTA) etc.
7. The composition according to claim 1 and 2, wherein said preservative is selected from the group consisting of benzoic acid and analogues, sorbic acid and analogues, arlagard and analogues, benzyl alcohol and analogues.
8. The composition according to claim 1 , wherein the composition is in the form of lotion, cream, foam and gel.
9. The composition according to claim 1 , wherein the urea can be further added in the cream form.
10. The composition according to claim 9, wherein the urea is preferably between 5 - 40% by weight of the composition.
11. The composition according to claim 1 , wherein triamcinolone is used as an active substance and a propellant is added in its form of foam.
12. The composition according to claim 11 , wherein the triamcinolone is between 0.1 - 1 % by weight and the propellant is between 0.1 - 5% by weight of the composition.
13. The composition according to claim 1 , wherein active substance bufexamac and a gel former sepigel 305 are added in its form of gel.
14. The composition according to claim 13, wherein the bufexamac is 1 - 5% by weight and the sepigel 305 is 1 - 5% by weight of the composition.
15. The composition according to claim 1 , wherein corticosteroid is preferably added.
16. The composition according to claim 15, wherein the corticosteroid is 0.001 - 2.5% by weight of the composition
17. The composition according to claim 1 and 2, wherein yoghurt is used as natural or used after drying processes like spraying, lyophilizing.
18. The composition according to any of claims 1 to 17, wherein analgesics, antihelmintics, antiallergics, antibiotics, antiseptics, antimycotics, external antiparasites, antiphlogistics, corticosteroids, sulfamides, cicatrising ingredients and active ingredients used for the treatment of burn can be added.
19. The use of a composition according to any of claims 1 to 18 in the preparation of dermatological product or pharmaceuticals for treatment of diseases like wounds, burns, eczema, psoriasis, atopic dermatitis and for regulating skin flora, removing dryness, nutritive and supporting skin barrier properties.
20. The composition according to any of claims 1 to 19, wherein said composition is applied topically to the skin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2006/06903A TR200606903A2 (en) | 2006-12-05 | 2006-12-05 | Dermatological formulations. |
| TR2006/06903 | 2006-12-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008068656A2 true WO2008068656A2 (en) | 2008-06-12 |
| WO2008068656A3 WO2008068656A3 (en) | 2009-01-15 |
Family
ID=38189236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2007/054552 WO2008068656A2 (en) | 2006-12-05 | 2007-11-09 | Dermatological compositions |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR200606903A2 (en) |
| WO (1) | WO2008068656A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170087083A1 (en) * | 2014-06-12 | 2017-03-30 | Henkel Ag & Co. Kgaa | Use of cosmetic cleaning compositions as a prebiotic |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108887289A (en) * | 2018-07-26 | 2018-11-27 | 上海沃必盛生物科技有限公司 | A kind of daily high effect disinfectants of family and its application method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2630560A1 (en) * | 1976-07-07 | 1978-01-12 | Bayer Ag | COSMETIC PREPARATIONS |
| EP1537847A1 (en) * | 2003-12-05 | 2005-06-08 | KPSS-Kao Professional Salon Services GmbH | Conditioning composition for hair |
| WO2006015675A1 (en) * | 2004-08-04 | 2006-02-16 | Henkel Kommanditgesellschaft Auf Aktien | Skin-cosmetic preparation based on multi- unsaturated fats |
| EP1733761A1 (en) * | 2005-06-07 | 2006-12-20 | KPSS-Kao Professional Salon Services GmbH | Oxidative colouring composition for keratin fibres comprising yogurt powder |
| WO2007000586A1 (en) * | 2005-06-29 | 2007-01-04 | Quest International Services B.V. | Improvements in skin and hair care |
| WO2008110942A1 (en) * | 2007-03-09 | 2008-09-18 | Orhan Vaizoglu | Cosmetic formulations |
-
2006
- 2006-12-05 TR TR2006/06903A patent/TR200606903A2/en unknown
-
2007
- 2007-11-09 WO PCT/IB2007/054552 patent/WO2008068656A2/en active Application Filing
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2630560A1 (en) * | 1976-07-07 | 1978-01-12 | Bayer Ag | COSMETIC PREPARATIONS |
| EP1537847A1 (en) * | 2003-12-05 | 2005-06-08 | KPSS-Kao Professional Salon Services GmbH | Conditioning composition for hair |
| WO2006015675A1 (en) * | 2004-08-04 | 2006-02-16 | Henkel Kommanditgesellschaft Auf Aktien | Skin-cosmetic preparation based on multi- unsaturated fats |
| EP1733761A1 (en) * | 2005-06-07 | 2006-12-20 | KPSS-Kao Professional Salon Services GmbH | Oxidative colouring composition for keratin fibres comprising yogurt powder |
| WO2007000586A1 (en) * | 2005-06-29 | 2007-01-04 | Quest International Services B.V. | Improvements in skin and hair care |
| WO2008110942A1 (en) * | 2007-03-09 | 2008-09-18 | Orhan Vaizoglu | Cosmetic formulations |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170087083A1 (en) * | 2014-06-12 | 2017-03-30 | Henkel Ag & Co. Kgaa | Use of cosmetic cleaning compositions as a prebiotic |
| US10085934B2 (en) * | 2014-06-12 | 2018-10-02 | Henkel Ag & Co. Kgaa | Use of cosmetic cleaning compositions as a prebiotic |
Also Published As
| Publication number | Publication date |
|---|---|
| TR200606903A2 (en) | 2007-04-24 |
| WO2008068656A3 (en) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7265298B2 (en) | Pharmaceutical composition | |
| US7557094B2 (en) | Skin cream composition | |
| WO2001085156A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
| JP2002504098A (en) | Tocopherol esters and their use in cosmetics and pharmaceuticals | |
| WO2008110942A1 (en) | Cosmetic formulations | |
| EP1069886B1 (en) | Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance | |
| US20100323040A1 (en) | Cosmetic composition for topical use comprising wasabi | |
| AU2016357227A1 (en) | Compositions containing natural extracts and use thereof for skin and hair | |
| CN114732760A (en) | Supermolecule fat milk glycerol glucoside composition, preparation method and application thereof, moisturizing skin care milk and moisturizing essence | |
| US20050063930A1 (en) | Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance | |
| KR100904370B1 (en) | Cosmetic Composition containing Nanoliposomes | |
| KR101325553B1 (en) | Cosmetic Composition for Protecting Skin Comprising Aminolevulinic acid Contained in Liquid Crystal Base | |
| US20040234628A1 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
| WO2008068656A2 (en) | Dermatological compositions | |
| US9011943B2 (en) | Compositions and methods for alleviating skin disorders | |
| US11484489B1 (en) | Skin care compositions and methods for regulating sebum production | |
| AU745463B2 (en) | Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect | |
| US20070225234A1 (en) | Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect | |
| KR20190017420A (en) | Cosmetic compositions for improving skin moisturizing | |
| WO2020247414A1 (en) | Topical composition and related methods | |
| CN114746077A (en) | Personal care compositions and methods for same | |
| KR20200136194A (en) | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment | |
| EP3150188A1 (en) | A topical composition of dexpanthenol for the treatment of diaper rash | |
| CN117919115A (en) | Skin care type skin plastid, preparation method and application thereof in cosmetics | |
| WO2023205499A1 (en) | Skin barrier protective delivery systems and methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07827034 Country of ref document: EP Kind code of ref document: A2 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07827034 Country of ref document: EP Kind code of ref document: A2 |